Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for GoodRx Holdings, Inc. (GDRX : NSDQ)

• Company Description    GoodRx Holdings Inc. provides consumer-focused digital healthcare platform. GoodRx Holdings Inc. is based in Santa Monica, California. Number of Employees: 738

• Price / Volume Information    Yesterday's Closing Price: $2.71 Daily Weekly Monthly 20 Day Moving Average: 1,899,170 shares Shares Outstanding: 339.43 (millions) Market Capitalization: $919.86 (millions) Beta: 1.45 52 Week High: $5.81 52 Week Low: $2.61 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -1.45% -1.29% 12 Week -41.60% -42.54% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2701 OLYMPIC BOULEVARD - SANTA MONICA,CA 90404 USA ph: 855-268-2822 fax: - ir@goodrx.com http://www.goodrx.com

• General Corporate Information    Officers Wendy Barnes - Chief Executive Officer; President and Director Trevor Bezdek - Chairman Christopher McGinnis - Chief Financial Office Romin Nabiey - Chief Accounting Office Christopher Adams - Director Peer Information GoodRx Holdings, Inc. (CHCR) GoodRx Holdings, Inc. (ESRX) GoodRx Holdings, Inc. (MYDP) GoodRx Holdings, Inc. (COR) GoodRx Holdings, Inc. (GBCS) GoodRx Holdings, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 38246G108 SIC: 7374 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/26/26 Share - Related Items Shares Outstanding: 339.43 Most Recent Split Date: (:1) Beta: 1.45 Market Capitalization: $919.86 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.06 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.28 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 9.48% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/26/26

• Fundamental Ratios P/E Current FY Estimate: 9.59 Trailing 12 Months: 15.06 PEG Ratio: 1.01 Price Ratios Price/Book: 1.53 Price/Cash Flow: 8.52 Price / Sales: 1.15 EPS Growth vs. Year Ago Period: 33.33% vs. Previous Quarter: -20.00% Sales Growth vs. Year Ago Period: 0.40% vs. Previous Quarter: -3.47% ROE 12/31/25 - - 09/30/25 - 9.73 06/30/25 - 8.86 ROA 12/31/25 - - 09/30/25 - 4.79 06/30/25 - 4.50 Current Ratio 12/31/25 - - 09/30/25 - 3.11 06/30/25 - 4.21 Quick Ratio 12/31/25 - - 09/30/25 - 3.11 06/30/25 - 4.21 Operating Margin 12/31/25 - - 09/30/25 - 7.97 06/30/25 - 7.53 Net Margin 12/31/25 - - 09/30/25 - 3.97 06/30/25 - 4.33 Pre-Tax Margin 12/31/25 - - 09/30/25 - 6.71 06/30/25 - 6.97 Book Value 12/31/25 - - 09/30/25 - 1.77 06/30/25 - 1.85 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - 0.81 06/30/25 - 0.75 Debt-to-Capital 12/31/25 - - 09/30/25 - 44.63 06/30/25 - 42.99

Powered by Zacks Investment Research ©